With a target price of Rs 1029.8, ICICI Direct has acquired a call on Sun Pharmaceutical Industries. Sun Pharmaceutical Industries is currently trading at Rs 1010. ICICI Direct advised keeping the stop loss at Rs 1006.3...
Rare diseases are described as potentially fatal or persistently debilitating conditions that affect a limited number of people. Novartis committed around $10 billion on total research and development (R&D) in 2022 and has already received 23...
Lupin Limited (Lupin) announced the opening of a new state-of-the-art Regional Reference Laboratory in Bengaluru, Karnataka, as part of its diagnostics network expansion. The establishment of the new laboratory is a significant step forward in...
care.ai, the first AI-powered Smart Care Facility Platform in healthcare, announced a long-term partnership with Google Cloud, making care.ai's innovative care solutions available on Google Cloud Marketplace. Healthcare organisations and care...
Glenmark Pharmaceuticals Ltd in India is considering selling a majority of its 82% stake in Glenmark Life Sciences Ltd in order to reduce its debt load, according to the Mint business daily on Tuesday. According to two people familiar with the....
Cipla Limited, a pharmaceutical company, has announced that it has signed a perpetual licence agreement with Novartis Pharma AG (Switzerland) to manufacture and market Galvus and Galvus combination brands for the treatment of type 2 diabetes...
WuXi STA, a global contract research, development, and manufacturing organisation (CRDMO), has expanded its Changzhou campus with two 2,000 L reactors and a large-scale continuous purification system for peptide manufacturing....
Insempra, a biology-powered firm that enables businesses to create superior goods with nature, has announced the release of its first functional component, a biotechnologically created, 100% natural alpha-Ionone flavour and fragrance ingredient...
With the rise of digital marketing, pharma companies can now reach their target audience more efficiently than ever before.
In order to ensure easy access to medicines at the right time, the Karnataka Price Monitoring Resource Unit (KPMRU) has been monitoring drug availability as the coronavirus disease (Covid-19) has emerged in various variants.
, CDSCO.jpg)
.jpg)